UV filters in cosmetics: Are they all safe for health?
More details
Hide details
1
Katedra i Zakład Chemii i Analizy Leków, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu, Śląski Uniwersytet Medyczny w Katowicach
2
Studenckie Koło Naukowe przy Katedrze i Zakładzie Chemii i Analizy Leków,
Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu, Śląski Uniwersytet Medyczny w Katowicach
Corresponding author
Dorota Małgorzata Wrześniok
Katedra i Zakład Chemii i Analizy Leków, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu, Śląski Uniwersytet Medyczny w Katowicach, ul. Jagiellońska 4, 41-200 Sosnowiec
Ann. Acad. Med. Siles. 2018;72:261-266
KEYWORDS
TOPICS
ABSTRACT
Tanning benefits not only the skeletal and cardiovascular system, but also stimulates the immune system. On the other hand, sunlight impairs the human body, leading to sunburn, keratinization and a decrease in skin firmness. Moreover, tanning can result in skin cancer, which can be prevented not only by avoiding sources of UV radiation, but also by using sun cosmetics. Unfortunately, not all the ingredients used in their production guarantee safety. The article presents the potential influence of two popular UV filters used in cosmetic sunscreens – 2-hydroxy-4-methoxybenzophenone (oxybenzone, BP-3) and 2-ethylhexyl 4-methoxycinnamate (octyl methoxycinnamate, OMC), on health.
REFERENCES (41)
1.
Rok J., Otręba M., Buszman E., Wrześniok D. Melanina – z melanocytu do keratynocytu, czyli jak przebiega transport melaniny w skórze. Ann. Acad. Med. Siles. 2012; 66(1): 60–66.
2.
Trzcionka J., Buszman E. Oddziaływanie antybiotyków tetracyklinowych z melaniną w aspekcie ich fototoksycznego działania na skórę. Ann. Acad. Med. Siles. 2003; 54–55: 55–63.
3.
Trzcionka J., Górna A., Buszman E. Rola melaniny w fotouczulającym działaniu sulfonamidów na skórę. Ann. Acad. Med. Siles. 2007; 61(6): 462–467.
4.
Beberok A., Buszman E., Zdybel M., Pilawa B., Wrześniok D. EPR examination of free radical properties of DOPA-melanin complexes with ciprofloxacin, lomefloxacin, norfloxacin and sparfloxacin. Chem. Phys. Lett. 2010; 497(1–3): 115–122.
5.
Buszman E., Betlej B., Wrześniok D., Radwańska-Wala B. Effect of metalions on melanin – local anaesthetic drug complexes. Bioinorg. Chem. Appl. 2003; 1(2): 113–122, doi: 10.1155/S1565363303000098.
6.
Fell G.L., Robinson K.C., Mao J., Woolf C.J., Fisher D.E. Skin β-endor-phin mediates addiction to UV light. Cell 2014; 157(7): 1527–1534, doi: 10.1016/j.cell.2014.04.032.
7.
Juzeniene A., Baturaite Z., Lagunova Z., Grigalavicius M., Porojnicu A.C., Bruland Ø.S., Moan J. Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females. Scand. J. Public Health 2015; 43(3): 324–330, doi:10.1177/1403494815572206.
8.
Toniato E., Spinas E., Saggini A., Kritas S.K., Caraffa A., Antinolfi P., Saggini R., Pandolfi F., Conti P. Immunomodulatory effects of vitamin D on skin inflammation. J. Biol. Regul. Homeost. Agents 2015; 29(3): 563–567.
9.
Pacholczyk M., Czernicki J., Ferenc T. Wpływ słonecznego promieniowania ultrafioletowego (UV) na powstawanie raków skóry. Med. Pr. 2016; 67(2): 255–266, doi: 10.13075/mp.5893.00342.
10.
Petersen B., Philipsen P.A., Wulf H.C. Skin temperature during sunbathing – relevance for skin cancer. Photochem. Photobiol. Sci. 2014; 13(8): 1123–1125, doi: 10.1039/c4pp00066h.
11.
Woźniak-Holecka J., Holecki T., Rokicka U. Sztuczne źródła promieniowania słonecznego jako czynnik ryzyka nowotworów skóry. Ann. Acad. Med. Siles. 2009; 63(6): 75–80.
14.
Bojarowicz H., Bartnikowska N. Kosmetyki ochrony przeciwsłonecznej. Część I. Filtry UV oraz ich właściwości. Probl. Hig. Epidemiol. 2014; 95(3): 596–601.
15.
Giokas D.L., Salvador A., Chisvert A. UV filters: From sunscreens to human body and the environment. TrAC 2007; 26(5): 360–374, doi: 10.1016/j.trac.2007.02.012.
16.
Kawakami C.M., Gaspar L.R. Mangiferin and naringenin affect the photostability and phototoxicity of sunscreens containing avobenzone. J. Photochem. Photobiol. B 2015; 151: 239–247, doi: 10.1016/j.jphotobiol.2015.08.014.
17.
Karta charakterystyki substancji chemicznej; Benzofenon czysty, 99%. Zgodny z Rozporządzeniem (WE) nr 1907/2006 (REACH), Załącznik II oraz Rozporządzeniem (WE) nr 1272/2008 (CLP) – Polska. Data wydania/Data aktualizacji: 2013-09-24. Avantor Performance Materials Poland Spółka Akcyjna [on-line] dostępne.
http://www.poch.com.pl/1/wysw/... A=524161c134bdb7240001.
18.
Spijker G.T., Schuttelaar M.L., Barkema L., Velders A., Coenraads P.J. Anaphylaxis caused by topical application of a sunscreen containing benzophenone-3. Contact Dermatitis 2008; 59(4): 248–249, doi: 10.1111/j.1600-0536.2008.01337.x.
19.
Pawar A.P., Gholap A.P., Kuchekar A.B., Bothiraja C., Mali A.J. Formulation and evaluation of optimized oxybenzone microsponge gel for topical delivery. J. Drug Deliv. 2015; 2015: 261068, doi: 10.1155/2015/261068.
20.
Lenique P., Machet L., Vaillant L., Bensaïd P., Muller C., Khallouf R., Lorette G. Contact and photocontact allergy to oxybenzone. Contact Dermatitis 1992; 26(3): 177–181.
21.
Collins P., Ferguson J. Photoallergic contact dermatitis to oxybenzone. Br. J. Dermatol. 1994; 131(1): 124–129.
22.
Kiec-Swierczynska M., Krecisz B., Swierczynska-Machura D. Photoallergic and allergic reaction to 2-hydroxy-4-methoxybenzophenone (sunscreen) and allergy to cetyl alcohol in cosmetic cream. Contact Dermatitis 2005; 53(3): 169–182.
23.
Veysey E.C., Orton D.I. Photoallergic contact cheilitis due to oxybenzone found in a lip cosmetic. Contact Dermatitis 2006; 55(1): 54.
24.
Klimová Z., Hojerová J., Beránková M. Skin absorption and human exposure estimation of three widely discussed UV filters in sunscreens – In vitro study mimicking real-life consumer habits. Food Chem. Toxicol. 2015; 83: 237–250, doi: 10.1016/j.fct.2015.06.025.
25.
Hanson K.M., Gratton E., Bardeen C.J. Sunscreen enhancement of UV-induced reactive oxygen species in the skin. Free Radic. Biol. Med. 2006; 41(8): 1205–1212.
26.
Zhang F., Zhang J., Tong C., Chen Y., Zhuang S., Liu W. Molecular interactions of benzophenone UV filters with human serum albumin revealed by spectroscopic techniques and molecular modeling. J. Hazard Mater. 2013; 263 (Pt 2): 618–626, doi:10.1016/j.jhazmat.2013.10.024.
27.
Pont A.R., Charron A.R., Brand R.M. Active ingredients in sunscreens act as topical penetration enhancers for the herbicide 2,4-dichlorophenoxyacetic acid. Toxicol. Appl. Pharmacol. 2004; 195(3): 348–354.
28.
Schlumpf M., Cotton B., Conscience M., Haller V., Steinmann B., Lichtensteiger W. In vitro and in vivo estrogenicity of UV screens. Environ. Health Perspect. 2001; 109(3): 239–244.
29.
Dębska S., Potemski P. Leczenie hormonalne chorych na raka piersi z nadekspresją receptora HER2. Onkol. Prakt. Klin. 2010; 6(6): 301–310.
30.
Ma R., Cotton B., Lichtensteiger W., Schlumpf M. UV filters with antagonistic action at androgen receptors in the MDA-kb2 cell transcriptional-activation assay. Toxicol. Sci. 2003; 74(1): 43–50.
31.
Schreurs R.H., Sonneveld E., Jansen J.H., Seinen W., van der Burg B. Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays. Toxicol. Sci. 2005; 83(2): 264–272.
32.
Kunisue T., Chen Z., Buck Louis G.M., Sundaram R., Hediger M.L., Sun L., Kannan K. Urinary Concentrations of Benzophenone-type UV Filters in US Women and Their Association with Endometriosis. Environ. Sci. Technol. 2012; 46(8): 4624–4632, doi:10.1021/es204415a.
33.
Wan Y., Xue J., Kannan K. Occurrence of benzophenone-3 in indoor air from Albany, New York, USA, and its implications for inhalation exposure. Sci. Total Environ. 2015; 537: 304–308, doi: 10.1016/j.scitotenv.2015.08.020.
34.
Gonzalez H., Jacobson C.E., Wennberg A.M., Larkö O., Farbrot A. Solid-phase extraction and reverse-phase HPLC: application to study the urinary excretion pattern of benzophenone-3 and its metabolite 2,4-dihydroxybenzophenone in human urine. Anal. Chem. Insights 2008; 3: 1–7.
35.
Schlumpf M., Kypkec K., Vöktd C.C., Birchlerd M., Durrerb S., Faassb O., Ehnesb C., Fuetschb M., Gailleab C., Henselerb M., Hofkampe L. et al. Endocrine Active UV Filters: Developmental Toxicity and Exposure Through Breast Milk. Chimia 2008; 62: 345–351.
36.
Krause M., Klit A., Blomberg Jensen M., Soeborg T., Frederiksen H., Schlumpf M., Lichtensteiger W., Skakkebaek N.E., Drzewiecki K.T. Sunscreens: are they beneficial for health? An overview of endocrine disrupting properties of UV-filters. Int. J. Androl. 2012; 35(3): 424–436, doi: 10.1111/j.1365-2605.2012.01280.x.
37.
Chhabra R.S. NTP technical report on the toxicity studies of benzophenone (CAS No. 119-61-9). Administered in feed to F344/N rats and B6C3F mice. Toxic Rep. Ser. 2000; (61): 1–53, A1–13.
38.
Rhodes M.C., Bucher J.R., Peckham J.C., Kissling G.E., Hejtmancik M.R., Chhabra R.S. Carcinogenesis studies of benzophenone in rats and mice. Food Chem. Toxicol. 2007; 45(5): 843–851.
39.
Okereke C.S., Kadry A.M., Abdel-Rahman M.S., Davis R.A., Friedman M.A. Metabolism of benzophenone-3 in rats. Drug Metab. Dispos. 1993; 21(5): 788–791.
40.
Kim S., Choi K. Occurrences, toxicities, and ecological risks of benzophenone-3, a common component of organic sunscreen products: a mini-review. Environ. Int. 2014; 70: 143–157, doi: 10.1016/j.envint.2014.05.015.
41.
Ko A., Kang H.S., Park J.H., Kwon J.E., Moon G.I., Hwang M.S., Hwang I.G. The association between urinary benzophenone concentrations and personal care product use in Korean adults. Arch. Environ. Contam. Toxicol. 2016; 70(4): 640–646, doi:10.1007/s00244-015-0240-x.